R 143
Pill imprint R 143 has been identified as Carbamazepine 200 mg.
Carbamazepine is used in the treatment of peripheral neuropathy; epilepsy; trigeminal neuralgia; bipolar disorder; schizoaffective disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy.
Carbamazepine 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Carbamazepine Images
- Imprint:
-
R
143 - Strength:
- 200 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
hypromellose
ethylcellulose
croscarmellose sodium
magnesium stearate
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Actavis
- National Drug Code (NDC):
- 00228-2143
Advertisement
More Carbamazepine resources
- Carbamazepine
- Carbamazepine (Wolters Kluwer)
- Carbamazepine Chewable Tablets (Wolters Kluwer)
- Carbamazepine Suspension (Wolters Kluwer)
- Carbamazepine Sustained-Release Capsules (Wolters Kluwer)
- Carbamazepine Sustained-Release Tablets (Wolters Kluwer)
- carbamazepine (Cerner Multum)
- carbamazepine (Micromedex) - Includes Dosage Information
- Carbamazepine (AHFS DI)
- Carbamazepine (FDA)
- Carbamazepine Capsules (FDA)
- Carbamazepine Chewable (FDA)
- Carbamazepine ER (FDA)
- Carbamazepine Oral Suspension (FDA)
- Carbamazepine (Wolters Kluwer)
Search Again
